Hans Olav Melberg

Hans Olav Melberg

Universitetet i Oslo

H-index: 21

Europe-Norway

About Hans Olav Melberg

Hans Olav Melberg, With an exceptional h-index of 21 and a recent h-index of 16 (since 2020), a distinguished researcher at Universitetet i Oslo, specializes in the field of Health economics, data science and health register research, causal inference, economic evaluation.

His recent articles reflect a diverse array of research interests and contributions to the field:

Opportunities and barriers for omics-based biomarker discovery in steatotic liver diseases

Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study

Infections Increase The Risk Of Decompensation And Death In Patients With Early Alcohol-Related Liver Disease

Nyttig perspektiv på overvektig populasjon

The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission

P860 The Costs of Inflammatory Bowel Diseases in High-Income Settings

Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease

P882 Regional differences in biologic and surgical treatment of inflammatory bowel disease in Norway 2011–2019

Hans Olav Melberg Information

University

Position

Associate professor of Health Economics

Citations(all)

1867

Citations(since 2020)

1019

Cited By

1294

hIndex(all)

21

hIndex(since 2020)

16

i10Index(all)

37

i10Index(since 2020)

21

Email

University Profile Page

Universitetet i Oslo

Google Scholar

View Google Scholar Profile

Hans Olav Melberg Skills & Research Interests

Health economics

data science and health register research

causal inference

economic evaluation

Top articles of Hans Olav Melberg

Title

Journal

Author(s)

Publication Date

Opportunities and barriers for omics-based biomarker discovery in steatotic liver diseases

Maja Thiele

Ida Falk Villesen

Lili Niu

Stine Johansen

Karolina Sulek

...

2024/3/28

Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study

Digestive and Liver Disease

Karoline Anisdahl

Sandre Svatun Lirhus

Asle W Medhus

Bjørn Moum

Hans Olav Melberg

...

2024/3/2

Infections Increase The Risk Of Decompensation And Death In Patients With Early Alcohol-Related Liver Disease

JHEP Reports

Stine Johansen

Simon Langkjær

Ditlev Nytoft Rasmussen

Mads Israelsen

Nikolaj Torp

...

2024/1/24

Nyttig perspektiv på overvektig populasjon

Tidsskrift for Den norske legeforening

Hans Olav Melberg

2023/9/19

The cost of inflammatory bowel disease in high-income settings: a Lancet Gastroenterology & Hepatology Commission

Johan Burisch

Mirabella Zhao

Selwyn Odes

Peter De Cruz

Severine Vermeire

...

2023/5/1

P860 The Costs of Inflammatory Bowel Diseases in High-Income Settings

Journal of Crohn's and Colitis

J Burisch

M Zhao

S Odes

P De Cruz

S Vermeire

...

2023/2/1

Validation of scores of PRO‐C3 to predict liver‐related events in alcohol‐related liver disease

Liver International

Stine Johansen

Mads Israelsen

Ida F Villesen

Nikolaj Torp

Mette J Nielsen

...

2023/7

P882 Regional differences in biologic and surgical treatment of inflammatory bowel disease in Norway 2011–2019

Journal of Crohn's and Colitis

K Anisdahl

SS Lirhus

AW Medhus

B Moum

HO Melberg

...

2023/2/1

Penger, prinsipper og prioritering

Tidsskrift for Den norske legeforening

Gudrun Waaler Bjørnelv

Hans Olav Melberg

2023/6/12

Adherence and persistence to pharmacotherapy in patients with heart failure: A nationwide cohort study, 2014–2020

ESC Heart Failure

Kristina Malene Ødegaard

Sandre Svatun Lirhus

Hans Olav Melberg

Jonas Hallén

Sigrun Halvorsen

2023/2

Healthy aging and future health spending

Nordic Journal of Health Economics

Hans Olav Melberg

Jan Sørensen

2023/12/21

Sphingolipids are depleted in alcohol-related liver fibrosis

Gastroenterology

Maja Thiele

Tommi Suvitaival

Kajetan Trošt

Min Kim

Andressa de Zawadzki

...

2023/6/1

Useful perspective on an overweight population

Tidsskrift for Den norske legeforening

Hans Olav Melberg

2023/9/27

Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Gastroenterology & Hepatology

Mads Israelsen

Bjørn Stæhr Madsen

Nikolaj Torp

Stine Johansen

Camilla Dalby Hansen

...

2023/6/1

Therapeutic management and outcomes in inflammatory bowel diseases, 2010 to 2017 in cohorts from Denmark, Sweden and Norway

Alimentary Pharmacology & Therapeutics

Mirabella Zhao

Sandre Lirhus

Mikael Lördal

Ebbe Langholz

Torben Knudsen

...

2022/9

New treatment for alcohol-related liver disease: combinations of efficacy and treatment cost required for cost-effectiveness

Journal of Hepatology

Maja Thiele

Davit Khlghatyan

Lars Asphaug

Stine Johansen

Hans Olav Melberg

2022/7/1

A nationwide registry study on heart failure in Norway from 2008 to 2018: variations in lookback period affect incidence estimates

BMC Cardiovascular Disorders

Kristina Malene Ødegaard

Sandre Svatun Lirhus

Hans Olav Melberg

Jonas Hallén

Sigrun Halvorsen

2022/3/5

Compliance to guideline-recommended pharmacotherapy in patients with heart failure, 2014 to 2020

European Heart Journal

KM Odegaard

SS Lirhus

J Hallen

HO Melberg

S Halvorsen

2022/10/1

Progressive alcohol‐related liver fibrosis is characterised by imbalanced collagen formation and degradation

Alimentary Pharmacology & Therapeutics

Maja Thiele

Stine Johansen

Natasja S Gudmann

Bjørn Madsen

Maria Kjærgaard

...

2021/10

What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study

BMJ open

Christoffer Bugge

Stein Kaasa

Erik Magnus Sæther

Hans Olav Melberg

Ivar Sonbo Kristiansen

2021/9/1

See List of Professors in Hans Olav Melberg University(Universitetet i Oslo)

Co-Authors

H-index: 118
Till W Bärnighausen

Till W Bärnighausen

Heidelberg University

H-index: 78
John N. Lavis

John N. Lavis

McMaster University

H-index: 68
Ole F. Norheim

Ole F. Norheim

Universitetet i Bergen

H-index: 66
Bjørn Moum, Professor & Consultant

Bjørn Moum, Professor & Consultant

Universitetet i Oslo

H-index: 60
joachim cohen

joachim cohen

Vrije Universiteit Brussel

academic-engine